These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 1937540

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Viral antigen induced autoimmunity: an animal model for diabetes mellitus type I].
    Hengartner H.
    Verh Dtsch Ges Pathol; 1994; 78():177-9. PubMed ID: 7533982
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes.
    Holz A, Dyrberg T, Hagopian W, Homann D, von Herrath M, Oldstone MB.
    J Immunol; 2000 Nov 15; 165(10):5945-53. PubMed ID: 11067957
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. T cells causing immunological disease.
    Zinkernagel RM, Pircher H, Ohashi PS, Hengartner H.
    Springer Semin Immunopathol; 1992 Nov 15; 14(2):105-13. PubMed ID: 1475738
    [Abstract] [Full Text] [Related]

  • 11. Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy.
    Speiser DE, Miranda R, Zakarian A, Bachmann MF, McKall-Faienza K, Odermatt B, Hanahan D, Zinkernagel RM, Ohashi PS.
    J Exp Med; 1997 Aug 29; 186(5):645-53. PubMed ID: 9271580
    [Abstract] [Full Text] [Related]

  • 12. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
    Althage A, Odermatt B, Moskophidis D, Kündig T, Hoffman-Rohrer U, Hengartner H, Zinkernagel RM.
    Eur J Immunol; 1992 Jul 29; 22(7):1803-12. PubMed ID: 1623925
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody.
    Seiler P, Senn BM, Bründler MA, Zinkernagel RM, Hengartner H, Kalinke U.
    J Immunol; 1999 Apr 15; 162(8):4536-41. PubMed ID: 10201992
    [Abstract] [Full Text] [Related]

  • 17. Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.
    Yanagi Y, Maekawa R, Cook T, Kanagawa O, Oldstone MB.
    J Virol; 1990 Dec 15; 64(12):5919-26. PubMed ID: 1700830
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.
    Pircher H, Bürki K, Lang R, Hengartner H, Zinkernagel RM.
    Nature; 1989 Nov 30; 342(6249):559-61. PubMed ID: 2573841
    [Abstract] [Full Text] [Related]

  • 20. Non-deletional mechanisms of peripheral and central tolerance: studies with transgenic mice with tissue-specific expression of a foreign MHC class I antigen.
    Hämmerling GJ, Schönrich G, Momburg F, Auphan N, Malissen M, Malissen B, Schmitt-Verhulst AM, Arnold B.
    Immunol Rev; 1991 Aug 30; 122():47-67. PubMed ID: 1834543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.